Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SafiledCriticalRhone Poulenc Rorer Sa
Priority claimed from PCT/FR1995/000533external-prioritypatent/WO1995028943A1/fr
Publication of MXPA96004986ApublicationCriticalpatent/MXPA96004986A/es
Publication of MX9604986ApublicationCriticalpatent/MX9604986A/es
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invencion se refiere a la utilizacion de la espiramicina, eventualmente en asociacion con metronidazol, para la preparacion de un medicamento destinado a al prevencion o al tratamiento de trastornos gastrointestinales en los que interviene Helicobacter pylori.
MX9604986A1995-04-241995-04-24Utilizacion de espiramicina en transtornos gastrointestinales causados por h. pylori.
MX9604986A
(es)
Sintesis de 11,12-hidrogenoortoborato de 9-desoxo-9a-aza-11,12-desoxi-9a-metil-9a-homoeritromicina a. un procedimiento para la preparacion de 9-desoxo-9a-aza-9a-metil-9a-homoeritromicina a dihidrato (azitromicina dihidrato).